Related Articles
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
Decreased human antigen R expression confers resistance to tyrosine kinase inhibitors in epidermal growth factor receptor-mutant lung cancer by inhibiting Bim expression
Angiogenic activities are increased via upregulation of HIF‑1α expression in gefitinib‑resistant non‑small cell lung carcinoma cells
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol